Coronary obstruction in transcatheter aortic valve-in-valve implantation: preprocedural evaluation, device selection, protection, and treatment

Affiliations

• ¹ From the Department of Cardiology, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada (D.D., J.L., P.B., D.A.W., D.S., J.G.W.); Department of Cardiology, Quebec Heart & Lung Institute, Laval University, Quebec City, Quebec, Canada (H.B.R., J.R.-C.); Department of Cardiology, Rabin Medical Center, Petach Tikva, Israel (R.K.); Department of Cardiology, Medstar Washington Hospital Center, DC (A.P., I.B.-D.); Department of Cardiology, Cardiovascular Center, Hospital San Borja Arriaran, Santiago, Chile (G.M.); and Department of Cardiology, Cedars-Sinai Heart Institute, Los Angeles, CA (R.R.M.).
• ² From the Department of Cardiology, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada (D.D., J.L., P.B., D.A.W., D.S., J.G.W.); Department of Cardiology, Quebec Heart & Lung Institute, Laval University, Quebec City, Quebec, Canada (H.B.R., J.R.-C.); Department of Cardiology, Rabin Medical Center, Petach Tikva, Israel (R.K.); Department of Cardiology, Medstar Washington Hospital Center, DC (A.P., I.B.-D.); Department of Cardiology, Cardiovascular Center, Hospital San Borja Arriaran, Santiago, Chile (G.M.); and Department of Cardiology, Cedars-Sinai Heart Institute, Los Angeles, CA (R.R.M.). john.webb@vch.ca.